This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock UPTD vs. CELZ, SLXN, BCLI, PMCB, TSBX, CHRO, OMGA, AIM, NKGN, and ALBTShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include Creative Medical Technology (CELZ), Silexion Therapeutics (SLXN), Brainstorm Cell Therapeutics (BCLI), PharmaCyte Biotech (PMCB), Turnstone Biologics (TSBX), Chromocell Therapeutics (CHRO), Omega Therapeutics (OMGA), AIM ImmunoTech (AIM), NKGen Biotech (NKGN), and Avalon GloboCare (ALBT). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. Creative Medical Technology Silexion Therapeutics Brainstorm Cell Therapeutics PharmaCyte Biotech Turnstone Biologics Chromocell Therapeutics Omega Therapeutics AIM ImmunoTech NKGen Biotech Avalon GloboCare TradeUP Acquisition (NASDAQ:UPTD) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Does the media favor UPTD or CELZ? In the previous week, Creative Medical Technology had 1 more articles in the media than TradeUP Acquisition. MarketBeat recorded 1 mentions for Creative Medical Technology and 0 mentions for TradeUP Acquisition. Creative Medical Technology's average media sentiment score of 1.32 beat TradeUP Acquisition's score of 0.67 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Overall Sentiment TradeUP Acquisition Positive Creative Medical Technology Positive Does the MarketBeat Community favor UPTD or CELZ? Creative Medical Technology received 71 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTradeUP AcquisitionN/AN/ACreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% Which has stronger earnings and valuation, UPTD or CELZ? TradeUP Acquisition has higher earnings, but lower revenue than Creative Medical Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTradeUP AcquisitionN/AN/A-$1MN/AN/ACreative Medical Technology$11K797.27-$5.29M-$3.71-0.54 Is UPTD or CELZ more profitable? TradeUP Acquisition's return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets TradeUP AcquisitionN/A N/A -3.38% Creative Medical Technology N/A -63.05%-60.42% Which has more risk & volatility, UPTD or CELZ? TradeUP Acquisition has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Do institutionals and insiders have more ownership in UPTD or CELZ? 35.0% of TradeUP Acquisition shares are owned by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are owned by institutional investors. 55.1% of TradeUP Acquisition shares are owned by company insiders. Comparatively, 2.8% of Creative Medical Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryTradeUP Acquisition and Creative Medical Technology tied by winning 5 of the 10 factors compared between the two stocks. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.52M$2.97B$5.55B$8.02BDividend YieldN/A1.87%5.09%4.23%P/E RatioN/A30.5222.6918.83Price / SalesN/A494.71404.28106.72Price / CashN/A168.6838.1834.62Price / Book-0.733.216.794.33Net Income-$1M-$72.35M$3.22B$247.97M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$1.16+1.8%N/A+8.4%$2.52MN/A0.002,021Gap UpCELZCreative Medical Technology1.3724 of 5 stars$1.99-3.9%N/A-56.0%$8.73M$11,000.00-0.525Upcoming EarningsNegative NewsSLXNSilexion TherapeuticsN/A$1.00+1.5%$5.00+400.0%N/A$8.56MN/A0.00N/AGap DownBCLIBrainstorm Cell Therapeutics3.7134 of 5 stars$1.16-10.8%$30.00+2,486.2%-78.9%$8.48MN/A-0.2440PMCBPharmaCyte Biotech1.4633 of 5 stars$1.18-5.2%N/A-44.0%$8.07MN/A2.224Positive NewsGap UpTSBXTurnstone Biologics3.1276 of 5 stars$0.35-4.8%$0.45+29.5%-86.6%$8.04M$19.31M-0.1182Positive NewsGap DownCHROChromocell TherapeuticsN/A$1.25+9.6%N/A-27.6%$7.63MN/A-0.854News CoverageGap UpOMGAOmega Therapeutics1.9253 of 5 stars$0.13-21.8%$9.20+7,260.0%-95.5%$6.92M$8.10M-0.09120Gap UpAIMAIM ImmunoTech1.689 of 5 stars$0.09-22.3%$2.75+2,908.8%-77.4%$6.61M$170,000.00-0.1920Gap DownHigh Trading VolumeNKGNNKGen BiotechN/A$0.13-18.9%N/A-90.4%$6.00M$80,000.00-0.03N/AGap UpALBTAvalon GloboCare1.2308 of 5 stars$3.55-4.8%N/A+0.2%$5.87M$1.31M-0.185Short Interest ↑ Related Companies and Tools Related Companies Creative Medical Technology Alternatives Silexion Therapeutics Alternatives Brainstorm Cell Therapeutics Alternatives PharmaCyte Biotech Alternatives Turnstone Biologics Alternatives Chromocell Therapeutics Alternatives Omega Therapeutics Alternatives AIM ImmunoTech Alternatives NKGen Biotech Alternatives Avalon GloboCare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPTD) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
